Navigation Links
Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
Date:1/28/2009

EAST BRUNSWICK, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that its biologics license application (BLA) for pegloticase for treatment-failure gout will be reviewed by the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) on March 5, 2009 as required for a drug of a new therapeutic class.

Savient submitted its BLA to the FDA on October 31, 2008 seeking approval to market pegloticase in the United States. On December 29, 2008, the FDA accepted the BLA filing for review and granted priority review. A priority review is an FDA designation that is assigned to products that if approved, would provide a significant improvement in the safety or effectiveness of the treatment, diagnosis or prevention of a serious or life-threatening disease. Under priority review, the target date for an FDA decision on the pegloticase BLA is April 30, 2009.

Savient's filing includes data from both the six-month placebo-controlled Phase 3 pivotal trials, as well as data from the open label extension (OLE) study. The two replicate six-month Phase 3 clinical trials for pegloticase were performed under the auspices of a Special Protocol Assessment (SPA) (2006). Pegloticase was granted orphan drug designation by the FDA in 2001.

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets. The Company's product development candidate, pegloticase for treatment-failure gout, has reported positive Phase 1, 2 and 3 clinical data. Patient dosing in the Phase 3 clinical studies began in June 2006; patient enrollment was completed in March 2007; and t
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... released on Tuesday, April 28, 2015.  On that day, ... webcast at 10:00 a.m. Eastern Time to discuss the ... by Pat Mackin , Chairman, President and Chief ...
(Date:4/21/2015)... Md. , April 21, 2015  The ... the U.S. Food and Drug Administration that the ... effectively for the last 25 years to protect ... safe homeopathic medicines. AAHP, the industry,s trade association, ... consumers of homeopathic medicines to engage in productive ...
(Date:4/21/2015)... , April 21, 2015  TissueGene, Inc. a ... therapies in the field of cell therapy, today ... the position of Chief Operating Officer.  Mr. Newman ... Management & Clinical Operations at ZIOPHARM Oncology, a ... employing novel gene expression, control and cell technologies ...
Breaking Medicine Technology:CryoLife Announces Release Date and Teleconference Call Details for 2015 First Quarter Financial Results 2Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2TissueGene, Inc. Hires Robert Newman as Chief Operating Officer 2
(Date:4/21/2015)... This year, in recognition of IAM, the Foundation ... publish a unique awareness campaign featuring real-life patients, affected ... of May and carry the message, "Be Inspired. Use ... was chosen to encourage the general public to learn ... support our mission of educating, inspiring and connecting all ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Carinsuranceshoppingsource.com ... of analyzing comprehensive auto insurance plans . ... it provides coverage for numerous situations. The coverage limit ... expensive. Comprehensive auto insurance will protect a car against ... , Comparing quotes is no longer difficult and ...
(Date:4/21/2015)... Park, CA (PRWEB) April 21, 2015 Dr. ... team at 101 Dental Group are now offering a valuable ... crown are included in the promotional price of only $1695 ... different specials available to patients for a limited time. ... cosmetic treatments simply based on the price," dental implants ...
(Date:4/21/2015)... 21, 2015 Autocarsinsurancetips.com has released a ... cost auto insurance plans by comparing quotes. ... find the best policies in their neighborhood. The insurance ... next best offer simply by comparing different plans. ... online car insurance quotes. Insurance brokerage websites like ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Optimity ... Information Technology advisory firm that helps clients in ... today announced that the Association of Community ... Preferred Vendor. ACAP represents 58 local, not-for-profit, community-affiliated ... than 13 million people primarily enrolled in public ...
Breaking Medicine News(10 mins):Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2Health News:Online Auto Insurance Quotes Can Help Clients Save Money 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2
... PLAINSBORO, N.J., July 7 As the most ... key role in their,patients, health and make more ... often than not, patients will follow these,recommendations. In ... the National Council on Patient Information and Education, ...
... Alterations in a molecular brain pathway activated by ... according to a report in the July issue of ... JAMA/Archives journals. , Expression of the cannabinoid 1 receptor ... ingredient of marijuana, is significantly reduced in the brains ...
... American Parkinson,Disease Association (APDA) has announced its 2008 ... Memorial Fellowship, a Dr. Roger Duvoisin,MD Grant, 31 ... student fellowships., David Hinkle, MD, PhD at ... that carries an $80,000 award for each of ...
... the risk seems bigger if certain painkillers are ... News) -- The widely prescribed class of antidepressants ... in the upper gastrointestinal tract, especially when taken ... study says. , Although reports of this effect ...
... Need to find a,Pennsylvania Dental Association (PDA) ... citizen living in Pennsylvania looking for reduced-fee dental,care? ... topics such as,brushing and flossing, fluoride or baby ... http://www.padental.org, is an excellent resource,providing patients this ...
... -- In a New York City metro-area first, a ... graft at NewYork-Presbyterian Hospital, the only center on the ... The new stent graft was implanted under an FDA-approved ... treat a complex form of abdominal aortic aneurysms in ...
Cached Medicine News:Health News:Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana 2Health News:American Parkinson Disease Association Awards More Than $3.7 Million to Research 2Health News:Popular Antidepressants Linked to GI Bleeding 2Health News:Popular Antidepressants Linked to GI Bleeding 3Health News:Pennsylvania Dental Association Website: A Great Resource for Pennsylvania Residents 2Health News:NYC first: Complex aneurysm treated using new fenestrated endograft stent 2
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles....
Sabre 180 is a powerful niche generator....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: